PALI insider: 64,400 cash‑settled phantom units granted to director
Rhea-AI Filing Summary
Palisade Bio director Donald Allen received a grant of 64,400 phantom units on 09/04/2025. Each phantom unit represents the economic equivalent of one share of Palisade Bio common stock. The award vests in three equal annual installments beginning August 5, 2026, provided the reporting person remains in continuous service through each vesting date. Vested phantom units will be settled solely in cash based on the fair market value of an equal number of shares upon termination of service, a liquidity change in control, or the seventh anniversary of the grant. The reporting person’s ownership after the grant is 64,400 common stock equivalents, held directly.
Positive
- Grant disclosed clearly: 64,400 phantom units awarded to director, with explicit vesting schedule and settlement terms
- Retention structure: Vesting in three equal annual installments beginning 08/05/2026 supports director continuity
Negative
- Cash settlement obligation: Vested phantom units are settled solely in cash, creating potential future cash liabilities for the company
- Timing risk: Vesting begins nearly a year after grant, delaying realization and potentially concentrating cash payouts in future periods
Insights
TL;DR: Director grant of cash-settled phantom units is a standard retention tool but creates a future cash obligation for the company.
The form shows a 09/04/2025 grant of 64,400 phantom units to a director, vesting in three equal annual installments starting 08/05/2026, contingent on continuous service. These units are cash-settled on vesting or certain triggering events, which creates a potential future cash liability rather than equity dilution. For governance review, key considerations include the size of the grant relative to other director compensation, the cash funding plan for settlements, and whether vesting terms align with shareholder interests. This disclosure is routine but material to assessing near-term cash obligations tied to executive/director compensation.
TL;DR: A sizeable phantom unit award for a director provides retention incentives but shifts payout risk to the company as cash settlements.
The reporting person beneficially owns 64,400 phantom units representing equivalent common shares. Vesting across three annual tranches beginning 08/05/2026 conditions retention. Settlement is expressly cash-only upon vesting or specified events, meaning the company will pay the fair market value in cash rather than issue shares. This affects cash flow planning and compensation expense recognition under accounting rules. The disclosure is specific and standard for non-qualified, cash-settled awards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Units | 64,400 | $0.00 | -- |
Footnotes (1)
- Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock. The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.
